0 0 Socialdiabetes Limited 11070116 true 2024-12-01 2025-11-30 2025-11-30 The principal activity of the company is manufacture of medical and dental instruments and supplies Digita Accounts Production Advanced 6.30.9574.0 true false 11070116 2024-12-01 2025-11-30 11070116 2025-11-30 11070116 bus:OrdinaryShareClass1 2025-11-30 11070116 bus:SmallEntities 2024-12-01 2025-11-30 11070116 bus:AuditExemptWithAccountantsReport 2024-12-01 2025-11-30 11070116 bus:FullAccounts 2024-12-01 2025-11-30 11070116 bus:SmallCompaniesRegimeForAccounts 2024-12-01 2025-11-30 11070116 bus:RegisteredOffice 2024-12-01 2025-11-30 11070116 bus:Director1 2024-12-01 2025-11-30 11070116 bus:OrdinaryShareClass1 2024-12-01 2025-11-30 11070116 bus:EntityNoLongerTradingButTradedInPast 2024-12-01 2025-11-30 11070116 bus:PrivateLimitedCompanyLtd 2024-12-01 2025-11-30 11070116 1 2024-12-01 2025-11-30 11070116 countries:EnglandWales 2024-12-01 2025-11-30 11070116 2023-12-01 2024-11-30 11070116 2024-11-30 11070116 bus:OrdinaryShareClass1 2024-11-30 xbrli:pure iso4217:GBP xbrli:shares

Registration number: 11070116

Socialdiabetes Limited
Annual Report and Unaudited Financial Statements
for the Year Ended 30 November 2025

Socialdiabetes Limited

Contents

Balance Sheet | 1
Notes to the Unaudited Financial Statements | 2 to 3

Socialdiabetes Limited

(Registration number: 11070116)
Balance Sheet as at 30 November 2025

| Note | 2025 £ | 2024 £
Current assets |  |  |
Cash at bank and in hand |  | 1 | 1
Capital and reserves |  |  |
Called up share capital | 4 | 1 | 1
Shareholders' funds |  | 1 | 1

For the financial year ending 30 November 2025 the company was entitled to exemption from audit under section 480 of the Companies Act 2006 relating to dormant companies.

Director's responsibilities:

• | The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476; and
• | The director acknowledges their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of accounts.

These financial statements have been prepared in accordance with the special provisions relating to companies subject to the small companies regime within Part 15 of the Companies Act 2006.

Approved and authorised by the director on 29 July 2026

......................................... Maria Jesus Salido Rojo Director

Socialdiabetes Limited

Notes to the Unaudited Financial Statements for the Year Ended 30 November 2025

1 | General information

The company is a private company limited by share capital, incorporated in England and Wales.

The address of its registered office is:
71 - 75 Shelton Street
Covent Garden
London
WC2H 9JQ
United Kingdom

These financial statements were authorised for issue by the director on 29 July 2026.

2 | Accounting policies

Summary of significant accounting policies and key accounting estimates

The principal accounting policies applied in the preparation of these financial statements are set out below. These policies have been consistently applied to all the years presented, unless otherwise stated.

Statement of compliance

These financial statements have been prepared in accordance with Financial Reporting Standard 102 Section 1A smaller entities - 'The Financial Reporting Standard applicable in the United Kingdom and Republic of Ireland' and the Companies Act 2006 (as applicable to companies subject to the small companies' regime).

Basis of preparation

These financial statements have been prepared using the historical cost convention except that as disclosed in the accounting policies certain items are shown at fair value.

Cash and cash equivalents

Cash and cash equivalents comprise cash on hand and call deposits, and other short-term highly liquid investments that are readily convertible to a known amount of cash and are subject to an insignificant risk of change in value.

Share capital

Ordinary shares are classified as equity. Equity instruments are measured at the fair value of the cash or other resources received or receivable, net of the direct costs of issuing the equity instruments. If payment is deferred and the time value of money is material, the initial measurement is on a present value basis.

3 | Staff numbers

The average number of persons employed by the company (including the director) during the year, was 0 (2024 - 0).

Socialdiabetes Limited

Notes to the Unaudited Financial Statements for the Year Ended 30 November 2025

4 | Share capital

Allotted, called up and fully paid shares

| 2025 | 2024
| No. | £ | No. | £
Ordinary of £1 each | 1 | 1 | 1 | 1

5 | Parent and ultimate parent undertaking

The company's immediate parent is Socialdiabetes SL, incorporated in Spain.